rss
Postgrad Med J 2006;82:40-45 doi:10.1136/pgmj.2005.038042
  • Original article

Application of Gleason analogous grading system and flow cytometry DNA analysis in a novel knock-in mouse prostate cancer model

  1. G Wu1,2,
  2. Lei Yu1,
  3. L Wang1,
  4. H Wang1,
  5. J W Xuan2
  1. 1Department of Urology, Xijing Hospital, the Fourth Military Medical University, Xi’an, China
  2. 2Department of Surgery, University of Western Ontario, London, Ontario, Canada
  1. Correspondence to:
 Dr G Wu and Dr H Wang
 Department of Urology, Xijing Hospital, the Fourth Military Medical University, Xi’an, China, 710032; wuguojun{at}fmmu.edu.cn; dusxjhw{at}fmmu.edu.cn
  • Received 5 June 2005
  • Accepted 17 July 2005

Abstract

Objective: A new knock-in mouse adenocarcinoma prostate model (KIMAP) was established, which showed a close to human kinetics of tumour development. This study used a new mouse histological grading system similar to the human Gleason grading system and flow cytometry DNA analysis to measure and compare the new KIMAP model with human CaP and transgenic mouse adenocarcinoma prostate (TGMAP) model.

Methods: According to heterogeneity of the clinical standard for prostate cancer diagnosis, a close to human mouse standard for histological grading and scoring system, Gleason analogous grading system, was established in this study. Sixty KIMAP and 48 TGMAP prostate cancer samples were measured and compared with human CaP. Flow cytometry DNA analysis was performed on malignant prostate tissues obtained from both TGMAP and KIMAP models.

Results: Mice with CaP from KIMAP (n = 60) and TGMAP (n = 48) models showed a different distribution of histological scores (p = 0.000). KIMAP mice showed higher percentage (53.3%) of compound histological score rate than TGMAP (25%), but closer to the human clinical average (50%), which showed significant correlation with age (p = 0.001), while TGMAP mice showed unbalanced and random score distribution in all age groups. Flow cytometry analyses showed that most tumour tissues in KIMAP were diploid, analogous to the human condition, while all the TGMAP mice showed aneuploid tumours.

Conclusions: Results of this study further show that KIMAP, a new generation of murine prostate cancer model, could be used as a supplementary model in addition to the currently widely used transgenic models.

Footnotes

  • Conflict of interests: G J Wu has been paid by the Fourth Military Medical University for running educational programmes and financial support for attendance at scientific meetings.

  • The first three authors contributed equally to this work.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.